Results hosted on duckduckgo.com
Show/hide filters
New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic — an update from the EU Early Warning System
December 2020
Drug-related deaths and mortality in Europe: update from the EMCDDA expert network
July 2019
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
June 2019
Drugs in syringes from six European cities: results from the ESCAPE project 2017
May 2019
Recent changes in Europe’s cocaine market: results from an EMCDDA trendspotter study
December 2018
Medical use of cannabis and cannabinoids: questions and answers for policymaking
Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System
June 2018
New psychoactive substances in prison
November 2017
High-risk drug use and new psychoactive substances – results from an EMCDDA trendspotter study
June 2017
November 2016
Hospital emergency presentations and acute drug toxicity in Europe — update from the Euro-DEN Plus research group and the EMCDDA
August 2016
Health responses to new psychoactive substances
June 2016
Recent changes in Europe’s MDMA/ecstasy market – results from an EMCDDA trendspotter study
May 2016
Drug-related infectious diseases in Europe. Update from the EMCDDA expert network
September 2015
New psychoactive substances in Europe: Innovative legal responses
June 2015
New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015)
March 2015
.